Vitale Salvatore Giovanni, Fulghesu Anna Maria, Mikuš Mislav, Watrowski Rafał, D'Alterio Maurizio Nicola, Lin Li-Te, Shah Mohsin, Reyes-Muñoz Enrique, Sathyapalan Thozhukat, Angioni Stefano
Obstetrics and Gynecology Unit, Department of General Surgery and Medical Surgical Specialties, University of Catania, 95124 Catania, Italy.
Division of Gynecology and Obstetrics, Department of Surgical Sciences, University of Cagliari, 09124 Cagliari, Italy.
Biomedicines. 2022 Jul 28;10(8):1816. doi: 10.3390/biomedicines10081816.
MicroRNAs (miRNAs) are small, non-coding RNAs that are essential for the regulation of post-transcriptional gene expression during tissue development and differentiation. They are involved in the regulation of manifold metabolic and hormonal processes and, within the female reproductive tract, in oocyte maturation and folliculogenesis. Altered miRNA levels have been observed in oncological and inflammatory diseases, diabetes or polycystic ovary syndrome (PCOS). Therefore, miRNAs are proving to be promising potential biomarkers. In women with PCOS, circulating miRNAs can be obtained from whole blood, serum, plasma, urine, and follicular fluid. Our systematic review summarizes data from 2010-2021 on miRNA expression in granulosa and theca cells; the relationship between miRNAs, hormonal changes, glucose and lipid metabolism in women with PCOS; and the potential role of altered miRNAs in fertility (oocyte quality) in PCOS. Furthermore, we discuss miRNAs as a potential therapeutic target in PCOS and as a diagnostic marker for PCOS.
微小RNA(miRNA)是一类小的非编码RNA,在组织发育和分化过程中对转录后基因表达的调控至关重要。它们参与多种代谢和激素过程的调节,在女性生殖道中,还参与卵母细胞成熟和卵泡发生。在肿瘤、炎症性疾病、糖尿病或多囊卵巢综合征(PCOS)中已观察到miRNA水平的改变。因此,miRNA正被证明是有前景的潜在生物标志物。在患有PCOS的女性中,循环miRNA可从全血、血清、血浆、尿液和卵泡液中获取。我们的系统综述总结了2010年至2021年关于颗粒细胞和卵泡膜细胞中miRNA表达的数据;PCOS女性中miRNA、激素变化、糖脂代谢之间的关系;以及PCOS中miRNA改变在生育力(卵母细胞质量)方面的潜在作用。此外,我们还讨论了miRNA作为PCOS潜在治疗靶点和PCOS诊断标志物的情况。